We are administering the seasonal flu vaccine. Please call for appointments. Walk-Ins welcome!
Patient Resources
- Home
- Patient Resources
- Search Results
Get Healthy!
Results for search "Cancer: Leukemia".
21 Oct
Study Links Global Rise in Cancer to Obesity Across All Age Groups
Researchers analyzed cancer trends in 42 countries and found a surge in certain cancer types in both young and older adults – with one exception.
22 Sep
Brave 9-Year-Old Donates Stem Cells to Help Save His Father’s Life
A young boy in Los Angeles donates stem cells to help his father beat leukemia. Doctors at Cedars-Sinai say he is one of their youngest and bravest donors.
Health News Results - 45
A Los Angeles-area dad is surviving leukemia thanks to his 10-year-old son, who earlier this year became the youngest-ever stem cell donor at Cedars-Sinai Medical Center.
Stephen Mondek’s donation provided a brand-new immune system for his father, Dr. Nick Mondek, who has been battling a...
- Dennis Thompson HealthDay Reporter
- |
- September 22, 2025
- |
- Full Page
Stricken with cancer in infancy, Jessica Lopez endured tumor-fighting treatments that saved her young life but also left her with lasting heart damage.
By the time she reached her early 30s, Lopez, who was left blind by her cancer, also found herself in triple-organ failure — her heart, liver and kidneys were shutting down.
A rare triple-organ transplant was deem...
- Ernie Mundell HealthDay Reporter
- |
- September 2, 2025
- |
- Full Page
Testing positive for leukemia actually saved the life of 51-year-old Jan Leahy, a business process owner from Wimbledon, England.
Leahy benefitted from a clinical trial evaluating a new bone marrow test that can detect a potential leukemia relapse months before standard exams.
In her case, the test showed she was no longer responding to chemotherapy for her leukemia, providing extra...
- HealthDay Reporter
- Dennis Thompson
- |
- May 5, 2025
- |
- Full Page
A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.
Researchers have prepared an off-the-shelf version of CAR immune cell treatment that can be administered more easily to patients with blood cancers.
The new treatment, whic...
- HealthDay Reporter
- Dennis Thompson
- |
- April 28, 2025
- |
- Full Page
Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds.
A special six-gene pattern can help predict who are more likely to respond well to Venclexta (venetoclax), a pill that promotes natural cell death among cancer cells, researchers said.
“By knowing...
- HealthDay Reporter
- Dennis Thompson
- |
- December 4, 2024
- |
- Full Page
A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show.
Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell acute lymphoblastic leukemia (ALL), and more than half (55%) went into remiss...
- HealthDay Reporter
- Dennis Thompson
- |
- December 3, 2024
- |
- Full Page
Growing up in a city with pockets of high radon levels, Matthew Bozigar wondered whether the radioactive gas might have anything to do with the high rates of cancer he saw around him, especially in young people.
"As an epidemiologist, I started considering possible environmental causes," said Bolzigar, an assista...
- HealthDay Reporter
- Carole Tanzer Miller
- |
- October 4, 2024
- |
- Full Page
Blood cancer patients of all races who receive cord blood transplants are now living longer.
The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipients has been eliminated.
"Outcomes for cor...
- HealthDay Reporter
- Carole Tanzer Miller
- |
- October 1, 2024
- |
- Full Page
Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.
First, blood cancers are far more common than you might think: One person in the United States is diagnosed with a
A German man has become the seventh person to apparently be cured of HIV, researchers report.
The 60-year-old man, referred to as the “next Berlin Patient,†was treated with a stem cell transplant in October 2015 for acute myeloid leukemia, researchers said.
He stopped taking the antiretroviral drugs needed to suppress HIV in September 2018, but has not developed any det...
- HealthDay Reporter
- Dennis Thompson
- |
- July 19, 2024
- |
- Full Page
Women who've undergone stem cell treatments for blood cancers, or for illnesses such as sickle cell disease, can successfully bring a pregnancy to term, new research shows.
The German findings run counter to the perceived wisdom on this issue: Many such patients are typically told that safe pregnancies are out of the question if they've undergone what's known as "allogeneic hemat...
- HealthDay Reporter
- Ernie Mundell
- |
- July 16, 2024
- |
- Full Page
CAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that the immunotherapy will create secondary cancers, a new study finds.
The U.S. Food and Drug Administration issued a warning in November 2023 about a risk of secondary cancers that might be associated with CAR-T cell therapy.
But a study of more than 700 patients treated at Stanford Univ...
- HealthDay Reporter
- Dennis Thompson
- |
- June 13, 2024
- |
- Full Page
An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds.
The drug, cyclophosphamide, could help patients receive a stem cell transplant even if the donor isn't a relative and only partially matches their blood type, researchers report.
Blood cancer patients had a high ...
- HealthDay Reporter
- Dennis Thompson
- |
- May 28, 2024
- |
- Full Page
Seniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted therapy for the blood cancer, a new study finds.
The oral drug venetoclax is typically given to older AML patients whose bodies can't handle the rigors of chemotherapy. The drug targets a protein in ...
- HealthDay Reporter
- Dennis Thompson
- |
- May 14, 2024
- |
- Full Page
For 14 years, David Perez fought fires in South Florida, thinking he was in peak physical shape. Then a routine physical turned up anomalies in his blood work that turned his life upside down.
"The labs came back irregular. Everything was off," Perez, 44, recalled. "I went to a hematologist and it wasn't until I saw the word cancer on the side of the building that I realized I might have ...
- HealthDay Reporter
- Lori Saxena
- |
- May 10, 2024
- |
- Full Page
Telehealth is revolutionizing health care in America by making it easier than ever to reach a doctor"but not everyone is benefitting, a new study reports.
People with limited English skills are more likely to have worse experiences with telehealth visits than people whose first language is English.
Folks who struggle with English were 40% more likely to rate video health care visits...
- HealthDay Reporter
- Dennis Thompson
- |
- May 10, 2024
- |
- Full Page
Some slow-growing cases of leukemia don't need constant surveillance by cancer specialists, a new study claims.
Low-risk patients with slow-growing chronic lymphocytic leukemia (CLL) and no symptoms fared well even after they stopped seeing doctors for specialized blood tests, researchers report.
The patients had fewer hospital visits, fewer infections and similar survival after thr...
- HealthDay Reporter
- Dennis Thompson
- |
- April 9, 2024
- |
- Full Page
Polycythemia vera is a rare form of blood cancer with few good treatment options, but that may soon change based on the results of a new clinical trial.
An injected experimental drug called rusfertide appears effective in reducing the excess production of red blood cells that's a hallmark of the disease.
"Rusfertide appears to represent a significant step forward in treating polycyt...
- HealthDay Reporter
- Ernie Mundell
- |
- February 26, 2024
- |
- Full Page
THURSDAY, Nov. 16, 2023 (Healthday News) -- While childhood cancer is no longer terminal for many, death rates remain higher in Black and Hispanic children, a new government report reveals.
Treatments for these rare cancers have improved drastically in recent decades, and death rates dropped for all children in 2001 -- and kept dropping for another decade.
But over the past 10 years...
- HealthDay Reporter
- Robin Foster
- |
- November 16, 2023
- |
- Full Page
CT scans are significantly linked to an increased risk of blood cancers in young people, a major multinational study has found.
Analysis of data from nearly 1 million people under 22 who underwent at least one CT scan found a strong and clear link between exposure to the scans' radiation and blood cancers, according to findings published Nov. 9 in the journal
While new treatments for leukemia have improved outcomes for many patients, children with Down syndrome have not benefited as much.
These young people are at increased risk for acute lymphoblastic leukemia (ALL) and have higher rates of relapse and treatment-related harm.
A new review looked at more contemporary therapi...
- HealthDay Reporter
- Cara Murez
- |
- November 1, 2023
- |
- Full Page
Diabetes may accelerate the growth of a blood cancer known as multiple myeloma, affecting overall survival, according to a new study.
The research, published Sept. 29 in the journal
Weight-loss surgery can deliver a host of health benefits, but new research reveals an unexpected one: Getting the surgery was associated with a 40% lower risk of blood cancers.
Being overweight or obese is a risk factor for several types of cancer, and women with obesity have a higher risk of cancer than men do.
In the study, researchers used data from the Swedish Obese Subjects (...
- HealthDay Reporter
- Cara Murez
- |
- September 25, 2023
- |
- Full Page
New research shows hard-to-diagnose blood disorders called myelodysplastic syndromes/neoplasms (MDS) are often misdiagnosed and a second opinion may be needed.
The difficulty of diagnosis and frequent misdiagnosis puts patients at increased risk for treatment mistakes and other potentially harmful consequences, according to researchers at the University of Miami's Sylvester Comprehensive ...
- HealthDay Reporter
- Cara Murez
- |
- August 9, 2023
- |
- Full Page
A growing obesity epidemic may affect the outcome of treatment for those dealing with cancer, according to a new study of adults and teens being treated for acute lymphoblastic leukemia (ALL).
Researchers called for further study of how weight affects the response to different chemotherapy regimens for ALL.
"We have known for roughly 15 years that obesity affects survival in pediatr...
- HealthDay Reporter
- Cara Murez
- |
- July 12, 2023
- |
- Full Page
Using gas stoves can increase indoor air levels of benzene, a chemical linked to higher risk of leukemia and other blood cell cancers, a new study reports.
Analysis of dozens of stoves revealed that a single gas cooktop burner on high or a gas oven set to 350 degrees Fahrenheit can raise indoor levels of benzene above those typically released by secondhand tobacco smoke, the researchers r...
- HealthDay Reporter
- Dennis Thompson
- |
- June 16, 2023
- |
- Full Page
Getting a single CT scan during childhood doesn't appear to increase a child's risk of a future brain tumor, leukemia or lymphoma, new research finds, but getting four or more scans more than doubles the chances.
CT scans use low-dose radiation, which can damage cells. Past evidence about the risks of cancer from these scans in children 18 and younger was conflicting, researchers said.
- HealthDay Reporter
- Cara Murez
- |
- April 24, 2023
- |
- Full Page
A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.
The treatment, called chimeric antigen receptor (CAR) T-cell therapy, is used to fight certain types of blood cancer -- including leukemia and lymphoma -- that have not responded to standard treatments.
It involves removing a patient's own immune system T-c...
- HealthDay Reporter
- Amy Norton
- |
- April 5, 2023
- |
- Full Page
If someone is stricken with a blood cancer or life-threatening clot, they'll probably fare better if they are white and wealthy, three new studies show.
The ongoing impact of patient race and income to medical outcomes was in the spotlight Saturday in New Orleans at the annual meeting of the American Society of Hematology (ASH).
In a promising development, new research has discovered that most adults with blood cancers develop at least some immunity to COVID-19 after getting booster shots.
"Our findings build on the wealth of literature showing that patients with
Getting a blood cancer diagnosis is devastating for young people, but it is also far more deadly if the patient is Black, new research shows.
The new study, which looked at outcomes for patients with acute myeloid leukemia (AML), highlights an urgent need to understand racial and ethn...
- HealthDay Reporter
- Cara Murez
- |
- July 7, 2022
- |
- Full Page
Leukemia at a young age is likely to affect survivors' longevity, a new study cautions.
Even when they're cured, teen and young adult survivors of leukemia have shorter life spans than those who've never had a blood cancer, researchers at the University of Texas MD Anderson Cancer Center found.
"We need to think about the long-term life span and the quality of life for our patients....
- HealthDay Reporter
- Robert Preidt
- |
- May 18, 2022
- |
- Full Page
Vaccines did a good job protecting most cancer patients against COVID-19, but those with blood cancers remain at risk for breakthrough infections, new research suggests.
The study analyzed nationwide data on more than 64,000 U.S. cancer patients who were vaccinated against SARS-CoV-2. The researchers looked a...
- HealthDay Reporter
- Cara Murez
- |
- April 6, 2022
- |
- Full Page
People with cancer may be at increased risk for a rare neurological disorder called Guillain-Barré syndrome, new research has found.
"Previous studies have suggested there may be a link between cancer and Guillain-Barré syndrome, but just how often people develop
Dozens of different spray products -- deodorants, shampoos, sunscreens, athlete's foot treatments -- have been recalled in recent months due to contamination with the cancer-causing chemical benzene.
Most recently, six Brut and Sure aerosol antiperspirants
More than 10 years after Doug Olsen underwent an experimental gene therapy that turned his T-cells into cancer killers, his leukemia has vanished, University of Pennsylvania doctors report.
"I'm doing great right now. I'm still very active. I wa...
- HealthDay Reporter
- Robin Foster and Robert Preidt
- |
- February 2, 2022
- |
- Full Page
Your fingerprints may be more than a surefire way to identify you: New research suggests their patterns may be linked to genes that guide limb development.
"People may wonder why our team is working on fingerprints," said co-senior study author Sijia Wang, a geneticist at the Shanghai Institute of Nutrition and Health in China. "We started the work purely out of curiosity. But later it tu...
- HealthDay Reporter
- Cara Murez
- |
- January 12, 2022
- |
- Full Page
Proctor & Gamble has voluntarily recalled several dry shampoo sprays and hair conditioner spray products with brand names Pantene, Herbal Essences, Aussie and Waterless because of benzene contamination.
This follows an earlier recall of some aerosol spray Old S...
For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy.
The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtype of the d...
- HealthDay Reporter
- Robert Preidt
- |
- December 14, 2021
- |
- Full Page
A gene therapy that could provide a permanent cure for sickle cell disease continues to show success through a third wave of patients, researchers report.
The therapy, LentiGlobin, restored normal blood function in 35 sickle cell patients who had the one-time procedure, according to clinical trial findings published Dec. 12 in the
Several Old Spice and Secret aerosol spray antiperspirants and hygiene products have been voluntarily recalled in the United States due to the presence of the cancer-causing chemical benzene, Proctor & Gamble says.
Benzene exposure can occur by inhalation, orally and through the skin. It can lead to cancers including leukemia and blood cancer of the bone marrow, as well as potentially lif...
- HealthDay Reporter
- Robert Preidt
- |
- November 30, 2021
- |
- Full Page
A COVID-19 vaccine booster shot gives cancer patients -- especially those with blood cancer -- much-needed protection, new research reports.
"Our study demonstrates in clear terms how the booster shot can make all the difference for some people with compromised immune systems, such as people with cancer," study co-author Dr. Balazs Halmos said in a news release from Montefiore Health Syst...
- HealthDay Reporter
- Robert Preidt
- |
- November 19, 2021
- |
- Full Page
People who were exposed to a particular hormonal medication in the womb may have a heightened risk of cancer later in life, a new study suggests.
Researchers found the increased cancer risk among adults whose mothers had been given injections of a synthetic progesterone known as 17-OHPC, or 17P, during pregnancy. The study participants were born in the 1960s, when the drug was used to hel...
- HealthDay Reporter
- Amy Norton
- |
- November 15, 2021
- |
- Full Page
Anti-vaxxers felt their suspicions confirmed when former U.S. Secretary of State Colin Powell died from COVID-19 complications in mid-October despite being fully vaccinated.
But Powell, 84, was being treated for blood cancer at the time of his death, and a new study reports that the COVID vaccines are producing little to no protection for some cancer patients.
Nearly 3 out of 5 bloo...
- HealthDay Reporter
- Dennis Thompson
- |
- October 27, 2021
- |
- Full Page
Patients with B-cell blood cancers who did not make antibodies to COVID-19 after two shots of vaccine may find that a third shot does the trick, new research finds.
More than half the patients who had failed to respond to the first two shots had a positive response to the third, or booster, shot, according to the Leukemia & Lymphoma Society study.
"The additional COVID-19 vaccine do...
- HealthDay Reporter
- Steven Reinberg
- |
- September 15, 2021
- |
- Full Page
Same Health Care Better Health !
Site Navigation
Contact Us
207 Broad Avenue, Palisades Park, NJ 07650
(201) 944-0863 - (201) 944-7110
2025 © All Rights Reserved. Privacy Policy